Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Molecular diagnostics involve a series of tests designed to identify genetic mutations that may indicate the presence of specific diseases, even in patients who do not exhibit any symptoms. These tests play a crucial role in diagnosing current disease states, monitoring ongoing conditions, and screening individuals for genetic predispositions to certain diseases. This can be particularly important for those who may benefit from preventive medical interventions. Prior to conducting molecular testing, it is essential to extract nucleic acids, such as DNA or RNA, from the specimens. The process of lysing cells is a critical step in this extraction, as it involves breaking down the cell walls and membranes using chemical agents. This action allows for the release of nucleic acids contained within the cells, making them available for subsequent analysis. The procedure can be applied to various types of specimens, including stool samples and paraffin-embedded tissues. The CPT® Code 83907 is specifically designated for reporting the lysis of cells prior to nucleic acid extraction for each specimen that undergoes this process.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure of lysing cells prior to nucleic acid extraction is indicated for various scenarios, including:
The procedure for lysing cells prior to nucleic acid extraction involves several critical steps, which are outlined as follows:
Post-procedure care primarily involves the proper handling and storage of the extracted nucleic acids to maintain their stability for future testing. It is essential to follow specific guidelines for the preservation of these samples, as degradation can occur if they are not stored under appropriate conditions. Additionally, any remaining specimens should be disposed of according to biohazard regulations to ensure safety and compliance with health standards. The results obtained from the molecular diagnostics can then be utilized for further clinical decision-making, including diagnosis, treatment planning, and genetic counseling.
| Short Descr | LYSE CELLS FOR NUCLEIC EXT | Medium Descr | MOLEC DX LYSIS CELLS PRIOR NUCLEIC ACID EXTRTJ | Long Descr | Molecular diagnostics; lysis of cells prior to nucleic acid extraction (eg, stool specimens, paraffin embedded tissue), each specimen | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.